Beam Therapeutics Inc (BEAM) PT Raised to $35 at RBC Capital
Tweet
Share
E-mailGet Alerts BEAM Hot Sheet
Price: $26.81 -0.15%
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $35.00 (from $27.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Brainsway (BWAY) PT Raised to $20 at BTIG
- Nomura/Instinet Upgrades Seiko Group Corp (8050:JP) to Buy
- Macquarie Upgrades Hankook Tire Co Ltd (161390:KS) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
